Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
Diagnostic Imaging
Return to: MDBR Home | Diagnostics | Diagnostic Imaging

Roche launches VENTANA DP 200 slide scanner for digital pathology

Published 27 March 2018

Roche has introduced VENTANA DP 200 high-speed slide scanner for digital pathology, which features tray-based design that enables no-touch slide processing for reduced workflow errors and produces better quality and reliability.

Roche Tissue Diagnostics head Ann Costello said: "The VENTANA DP 200 slide scanner provides the pathology lab with image quality and ease of use that sets a new standard for digital pathology.

"As more and more labs seek to adopt this important technology, we are proud to create the efficiencies that empower faster and better diagnosis and treatment of cancer. This launch is a major milestone in our ongoing commitment to the advancement of patient care through digital pathology and provides a foundation for a future menu of Roche image analysis algorithms."

Additional features of the VENTANA DP 200 include scan speed of less than 49 seconds for 15-by-15 millimeter scan area, and the application of a unique International Color Consortium (ICC) color profile to each image to ensure that the digital image closely matches colors observed under a microscope.

The VENTANA DP 200 provides reliable, high-speed scanning of histology slides for digital pathology, with excellent image quality.

The VENTANA DP 200 is Digital Imaging and Communications in Medicine (DICOM) Standard compatible and integrates with Image Management Servers, including VENTANA Virtuoso software. It is CE marked by the European Commission for in-vitro diagnostic use and is available in the US for research use only (RUO).1

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives.

The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.

Roche is also the world leader in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Source: Company Press Release